Literature DB >> 14729629

Roles of phosphatidylinositol 3'-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells.

Jinyi Shao1, B Mark Evers, Hongmiao Sheng.   

Abstract

Phosphatidylinositol 3'-kinase (PI3K) activity is required for Ras- mediated transformation of intestinal epithelial cells (IECs). The mammalian target of rapamycin (mTOR) and its downstream pathways control the translation of specific mRNAs that are required for cell proliferation and transformation. Here, we elucidated the roles of PI3K and mTOR in K-Ras-mediated transformation of IECs (IEC-6). Induction of K-Ras activated PI3K and mTOR in IECs. p70 ribosomal protein S6 kinase activity was induced by K-Ras in a PI3K- and mTOR-dependent manner. K-Ras did not significantly alter the phosphorylation of eukaryotic initiation factor 4E-binding protein 1. Treatment with either LY-294002 or rapamycin inhibited IEC proliferation and resulted in G(1) growth arrest. However, it was noted that inhibition of mTOR enhanced K-Ras-mediated morphological transformation and increased invasiveness of IECs in a mitogen-activated protein/extracellular signal-regulated kinase-dependent manner. Furthermore, inhibition of PI3K or mTOR impaired the growth of an array of colon cancer cells. Spindle transformation, reduced E-cadherin, and increased invasiveness were observed in LY-294002-treated Moser cells. Thus, our results suggest that K-Ras-mediated transformation of IECs involves activation of the PI3K/mTOR pathway. Inhibition of PI3K/mTOR activity leads to G(1) growth arrest of transformed IECs. On the other hand, inhibition of PI3K or mTOR may induce the epithelial to mesenchymal transdifferentiation of IECs under certain circumstances.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729629     DOI: 10.1158/0008-5472.can-03-1859

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  AMP-activated protein kinase regulates the assembly of epithelial tight junctions.

Authors:  Li Zhang; Ji Li; Lawrence H Young; Michael J Caplan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

2.  The protective role of interleukin-11 against neutron radiation injury in mouse intestines via MEK/ERK and PI3K/Akt dependent pathways.

Authors:  Leilei Yang; Ruijuan Wang; Yabing Gao; Xinping Xu; Kaifei Fu; Shaoxia Wang; Yang Li; Ruiyun Peng
Journal:  Dig Dis Sci       Date:  2014-01-23       Impact factor: 3.199

Review 3.  The LKB1 complex-AMPK pathway: the tree that hides the forest.

Authors:  Michaël Sebbagh; Sylviane Olschwang; Marie-Josée Santoni; Jean-Paul Borg
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

4.  Age-dependent reduction of the PI3K regulatory subunit p85α suppresses pancreatic acinar cell proliferation.

Authors:  Hitoshi Takahashi; Daiki Okamura; Marlene E Starr; Hiroshi Saito; B Mark Evers
Journal:  Aging Cell       Date:  2012-02-01       Impact factor: 9.304

5.  Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.

Authors:  Piotr G Rychahou; Lindsey N Jackson; Scott R Silva; Srinivasan Rajaraman; B Mark Evers
Journal:  Ann Surg       Date:  2006-06       Impact factor: 12.969

6.  Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.

Authors:  Ming Yu; William M Grady
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

7.  Requirement of phospholipase D1 activity in H-RasV12-induced transformation.

Authors:  F Gregory Buchanan; Matt McReynolds; Anthony Couvillon; Yoonseok Kam; Vijaykumar R Holla; Raymond N Dubois; John H Exton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

8.  FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells.

Authors:  Silvia Fernández de Mattos; Priam Villalonga; Jon Clardy; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

9.  Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.

Authors:  Teruaki Fujishita; Koji Aoki; Heidi A Lane; Masahiro Aoki; Makoto M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

10.  PTHrP increases xenograft growth and promotes integrin alpha6beta4 expression and Akt activation in colon cancer.

Authors:  Xiaoli Shen; Piotr G Rychahou; B Mark Evers; Miriam Falzon
Journal:  Cancer Lett       Date:  2007-10-26       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.